Fig 1.
Flow diagram.
Table 1.
Baseline and demographic characteristics of the study cohort.
Table 2.
Crude associations between participant characteristics and anti-measles IgG levels at enrolment.
Fig 2.
Anti-measles IgG levels at respective time points for each treatment group.
Group A received praziquantel (PZQ) 2 weeks before measles immunization (MI), Group B received PZQ at the time of MI, Group C received PZQ one week after MI and Group D was S mansoni negative and did not receive PZQ. Shown on the dot plots are medians with inter-quartile whiskers and the Wilcoxon Signed-rank paired sample test p-values.
Table 3.
Association of S mansoni infection with antibody levels one and 24 weeks following measles catch-up immunisation.
Table 4.
Effect of praziquantel treatment on antibody levels.
Fig 3.
Measles specific IgG levels at one week after catch-up immunization.
Error bars shown are median and interquartile whiskers and Wilcoxon rank-sum (Mann-Whitney) test p-values.